Page last updated: 2024-08-22

molindone and clozapine

molindone has been researched along with clozapine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's2 (18.18)18.2507
2000's6 (54.55)29.6817
2010's0 (0.00)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S1
Glennon, RA1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Salama, AI; Saller, CF1
Barrett, JE1
Geibig, CB; Marks, LW1
Allison, DB; Cappelleri, JC; Chandler, LP; Heo, M; Infante, MC; Mentore, JL; Weiden, PJ1
Glazer, WM1
Tiihonen, J; Tuominen, HJ; Wahlbeck, K1
Cho, DY; Lindenmayer, JP1
Arango, C; Leucht, S; Lopez-Morinigo, JD1

Reviews

5 review(s) available for molindone and clozapine

ArticleYear
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
    Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14

    Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists

2003
Antipsychotic-induced weight gain: a comprehensive research synthesis.
    The American journal of psychiatry, 1999, Volume: 156, Issue:11

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Confidence Intervals; Drug Administration Schedule; Humans; Molindone; Piperazines; Placebos; Psychotic Disorders; Research Design; Thiazoles; Treatment Outcome; Weight Gain

1999
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 4

    Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis

2000
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis.
    Schizophrenia research, 2005, Jan-01, Volume: 72, Issue:2-3

    Topics: Clozapine; Cycloserine; Dioxoles; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Agents; Glycine; Humans; Hydro-Lyases; Molindone; Piperidines; Schizophrenia

2005
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
    Pharmacopsychiatry, 2022, Volume: 55, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic

2022

Trials

1 trial(s) available for molindone and clozapine

ArticleYear
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 4

    Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis

2000

Other Studies

6 other study(ies) available for molindone and clozapine

ArticleYear
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:3

    Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain

2003
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Naunyn-Schmiedeberg's archives of pharmacology, 1986, Volume: 334, Issue:2

    Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Buspirone; Carbazoles; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluphenazine; Haloperidol; Male; Molindone; Pargyline; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Regression Analysis

1986
Comparison of the effects of antipsychotic drugs on the schedule-controlled behavior of squirrel monkeys and pigeons.
    Neuropharmacology, 1983, Volume: 22, Issue:4

    Topics: Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Columbidae; Conditioning, Psychological; Haloperidol; Male; Molindone; Promazine; Saimiri; Species Specificity; Thiothixene

1983
Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:10

    Topics: Agranulocytosis; Clozapine; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Middle Aged; Molindone; Recombinant Proteins

1993
Aripiprazole-induced agitation after clozapine discontinuation: a case report.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:1

    Topics: Akathisia, Drug-Induced; Alcoholism; Antipsychotic Agents; Aripiprazole; Clozapine; Cocaine-Related Disorders; Comorbidity; Delayed-Action Preparations; Diabetic Ketoacidosis; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Middle Aged; Molindone; Piperazines; Quinolones; Schizophrenia, Paranoid; Substance Withdrawal Syndrome

2009